MDA Taps Global Health Care Leader as CEO to Leverage New Breakthroughs and Amplify Mission

Lynn O’Connor Vos will lead new era of neuromuscular disease research and services to transform and save lives

After a nationwide search, the Muscular Dystrophy Association (MDA) today announced it has appointed Lynn O’Connor Vos as President and Chief Executive Officer. Vos previously was Global Chief Executive Officer of Greyhealth Group (ghg), a leading health care communications agency and part of the global WPP Group.

“It truly feels as if my entire career path has been leading me to this role,” said Vos. “I am excited to bring my passion for patient care and advocacy, as well as my success using new technology to build new, innovative communication approaches, to lead MDA in the fast-changing world of research and patient care.”

With pediatric nursing as an early base, Vos has built successful health companies by applying trailblazing technology to new programs and efficiencies in patient care. She is the co-creator of Text4baby, the country’s top mobile health program that has changed the health outcomes of mothers and infants. She has achieved additional success forging relationships and partnerships with institutions, providers and nonprofits to effect change and make a lasting impact in health care.

“We are grateful to have Lynn on board,” said MDA Chairman of the Board R. Rodney Howell, M.D. “She is joining MDA at an incredibly important time for our organization, when the pipeline of promise in research is yielding more new drug approvals than ever before. I look forward to working with her as we continue to support MDA families through every stage of their journey with neuromuscular disease.”

Vos succeeds interim President and CEO Kristine Welker. A former Hearst Corporation executive, Welker has served in the interim role since February and will immediately resume her volunteer role as a member of MDA’s Board of Directors.

“The inspiration stemming from new drug breakthroughs, together with the incredible impact of ongoing, community fundraising initiatives like the current ‘Live Unlimited’ campaign, inspire me to also seek to defy limits the way MDA families do,” added Vos. “And I know the unprecedented leaders in corporate social responsibility that MDA has as its partners are right beside us as we continue to transform and save lives.”

About Lynn O’Connor Vos – MDA President and CEO

Vos will bring broad leadership capacity to MDA. She held her CEO position at ghg for nearly 23 years and is credited with creating, building and acquiring companies — specifically, nine acquisitions — to grow ghg’s global footprint. While at ghg, Vos led global expansion and diversification strategies and within two years grew the company from a small, domestic professional player into an award-winning global enterprise with fully integrated, multi-channel offerings. She is a recognized thought leader in the industry with published white papers and articles outlining new, successful approaches to health care technology and communications.

Honors and Positions

  • Named an MM&M Healthcare Transformer and a member of the PharmaVoice 100 and, in 2016, a PM360 Elite Transformational Leader and an MM&M Top 50 Health Influencer.
  • Woman of the Year (2005) by the Healthcare Business Women’s Association.
  • Corporate Achievement Award (2006) from the Jed Foundation.
  • Member of Women Leading Healthcare (WBL).
  • Advisory member of Armory Square Ventures, focused on early stage ventures and evaluating and advising health care startup investments.
  • Board member of The Jed Foundation and OptimizeRX (OPRX).
  • Member of the Kraft Precision Medicine Accelerator at Harvard Business School.

Join Lynn in the quest to help kids and adults living with neuromuscular diseases live longer and grow stronger.

Live Unlimited